IRIS
FARINA, DEBORAH
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.789
EU - Europa 1.724
AS - Asia 1.681
SA - Sud America 223
Continente sconosciuto - Info sul continente non disponibili 69
AF - Africa 30
OC - Oceania 3
Totale 6.519
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.720
CN - Cina 565
SG - Singapore 561
UA - Ucraina 258
IE - Irlanda 255
GB - Regno Unito 204
BR - Brasile 181
TR - Turchia 181
RU - Federazione Russa 178
SE - Svezia 176
IT - Italia 167
DE - Germania 163
FR - Francia 162
VN - Vietnam 148
FI - Finlandia 78
IN - India 78
CA - Canada 35
HK - Hong Kong 34
BD - Bangladesh 24
CZ - Repubblica Ceca 18
MX - Messico 18
AR - Argentina 17
JP - Giappone 17
PL - Polonia 14
ZA - Sudafrica 13
ES - Italia 10
IR - Iran 10
IQ - Iraq 9
CO - Colombia 8
NL - Olanda 8
CH - Svizzera 7
ID - Indonesia 7
BE - Belgio 6
PK - Pakistan 6
PY - Paraguay 6
AE - Emirati Arabi Uniti 5
EU - Europa 5
JO - Giordania 5
LT - Lituania 5
MA - Marocco 5
SA - Arabia Saudita 5
EC - Ecuador 4
JM - Giamaica 4
KR - Corea 4
NP - Nepal 4
RS - Serbia 4
TN - Tunisia 4
AU - Australia 3
CL - Cile 3
CR - Costa Rica 3
IL - Israele 3
KE - Kenya 3
BG - Bulgaria 2
BH - Bahrain 2
EG - Egitto 2
GR - Grecia 2
GT - Guatemala 2
HR - Croazia 2
LB - Libano 2
MY - Malesia 2
PH - Filippine 2
PR - Porto Rico 2
UY - Uruguay 2
UZ - Uzbekistan 2
VE - Venezuela 2
AO - Angola 1
AT - Austria 1
AZ - Azerbaigian 1
BB - Barbados 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
HT - Haiti 1
HU - Ungheria 1
LV - Lettonia 1
MD - Moldavia 1
MM - Myanmar 1
NI - Nicaragua 1
OM - Oman 1
RO - Romania 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
Totale 6.455
Salva come PNG Salva come JPEG
Città #
Singapore 424
Chandler 323
Jacksonville 307
San Jose 259
Dublin 253
Beijing 178
Ashburn 171
Dallas 168
Southend 152
Council Bluffs 118
Princeton 108
The Dalles 100
Izmir 92
Nanjing 89
Los Angeles 71
New York 59
Dearborn 58
Wilmington 58
Munich 54
Ho Chi Minh City 53
Santa Clara 52
Cambridge 49
Altamura 37
Tongling 36
Hanoi 33
Hong Kong 33
Nanchang 33
Moscow 29
Ann Arbor 28
Montreal 21
Shenyang 21
São Paulo 20
Buffalo 18
Chieti 16
Denver 15
Turku 15
Washington 15
Frankfurt am Main 14
Hebei 14
Jiaxing 14
Kunming 14
Tianjin 14
Boardman 13
Brooklyn 13
Hangzhou 13
Helsinki 13
Tokyo 13
Woodbridge 13
Brno 12
Changsha 12
Grevenbroich 12
Redondo Beach 12
Warsaw 12
Atlanta 11
Jinan 11
Mexico City 11
Orem 11
Norwalk 10
Phoenix 10
Poplar 10
Guangzhou 9
Stockholm 9
Ardabil 8
Augusta 8
Houston 8
Johannesburg 8
Monmouth Junction 8
Amsterdam 7
Boston 7
Camerino 7
Chennai 7
Chicago 7
Columbus 7
Fermo 7
London 7
San Francisco 7
San Mateo 7
Campobasso 6
Da Nang 6
Fribourg 6
Hải Dương 6
Lanzhou 6
Manchester 6
Rio de Janeiro 6
Rome 6
Toronto 6
Amman 5
Biên Hòa 5
Brussels 5
Leawood 5
Ningbo 5
Baghdad 4
Belgrade 4
Belo Horizonte 4
Brasília 4
Changchun 4
Curitiba 4
Florence 4
Hefei 4
Milan 4
Totale 4.091
Salva come PNG Salva come JPEG
Nome #
Autologous hematopoietic stem cell transplantation in multiple sclerosis: A meta-analysis 171
A lipidomic investigation for the caracterisation of CSF lipid profile in patients with multiple sclerosis 167
Effetti sinergici della terapia con interferone-beta sulla attivazione. Adesione ed apoptosi linfocitaria nella sclerosi multipla esacerbante /remittente. (C22) 166
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone 163
Cognitive dysfunction in patients with relapsing-remitting Multiple Sclerosis 161
Increasing age at disability milestones among MS patients in the MSBase Registry 154
Chemokines are Modulated by Interferon beta 1B (IFNT-Beta IB) in Relapsing-Remitting Multiple Sclerosis (RR-MS) 151
Alemtuzumab treatment of multiple sclerosis in real-world clinical practice: A report from a single Italian center 151
The Multiple Sclerosis Knowledge Questionnaire: a self administered instrument for recently diagnosed patients 148
Effetti sinergici della terapia con interferone-beta sulla attivazione, adesione ed apoptosi linfocitaria nella sclerosi multipla esacerbante/remittente 147
Development of methods for lipid extraction from CSF and application of mass spectometry techniques for the characterization of the lipid profile and neurosteroids levels in MS patients 145
An information aid for newly diagnosed multiple sclerosis patients improves disease knowledge and satisfaction with care. 143
Metabolomics analysis of cerebrospinal fluid reveals a distintive biochemical alteration associated with multiple sclerosis. 142
Convulsive status epilepticus due to new encephalic demyelinating lesions in multiple sclerosis 140
A difficult pediatric case: ADEM evolving in multiple sclerosis complicated by progressive multifocal leukoencephalopathy after Natalizumab treatment. 138
Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome. 137
Anti-JCV serostatus, index value and clinical features in patients affected by multiple sclerosis. 135
Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS. 134
Brain tissue loss occurs after suppression of enhancement in patients with multiple scerosis treated with autologous haematopoietic stem cell transplantation. 133
Experience of an information aid for newly diagnosed multiple sclerosis patients: a qualitative study on the SIMS-Trial 131
MCP-1 expression and secretion in adherent monocyte cultures from multiple sclerosis patients treated with interferon beta-1b 128
The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry. 128
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy. 125
Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosis. 125
The Chieti experience with Interferon B1b (IFNB1b) during the first 2 years: side effects. 124
JCV-Ab serostatus in MS patients treated with Natalizumab 124
The Chieti Experience with interferon B1b (IFNB1b) during the first 2 years: Efficacy 121
Interferone beta: effetti collaterali 121
Multiphasic Adem or Multiple Sclerosis? Treatement implications. 119
Mass spectrometry based metabonomics of the cerebrospinalfluid highlights a correlation between polar lipids and carnitines levels in multiple sclerosis patients. 118
Natalizumab-associated PML-IRIS: the Chieti experience. 118
Low dose oral methotrexate (MTX) in chronic progressive (CP) multiple sclerosis (MS) 116
Pregnancy outcomes and disease activity after exposure to natalizumab in patients with multiple sclerosis 114
Pregnancy outcomes and disease activity after exposure to natalizumab in patients with multiple sclerosis 114
The long-term effect of AHSCT on MRI measures of MS evolution: a five-year follow-up study 114
Neuropsychological testing and quantitative electroencephalography: a search of neurophysiological markers of cognitive decline in multiple sclerosis 111
Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database. 111
Autologous HSCT for severe progressive Multiple Sclerosis in a multicenter trial: impact on disease activity and quality of life 110
Real-life impact of early interferon beta therapy in relapsing multiple sclerosis 109
Prevalence of JC virus antibodies in human serum and seroconversion rate with first-generation and second generation ELISA: the novel assay improves specificity andsensitivity to detect anti-JC virus antibodies 107
Treatment discontinuation issues in fingolimod treated patients: the Chieti experience. 99
Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre study 99
Lymphomononuclear cells from multiple scerosis patients spontaneously produce high levels of oncostatin M, tumor necrosis factors alpha and beta, and interferon gamma. 98
Progressive multifocal leukoencephalopathy associated with natalizumab in paediatric multiple sclerosis 98
Simultaneous early-onset severe autoimmune hemolytic anemia and albuminuria during alemtuzumab treatment for multiple sclerosis 98
Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis 97
Neuropsychological testing and event-related potentials: markers of cognitive impairment in patients with multiple sclerosis 94
Pregnancy does not prevent disease re-activation after natalizumab suspension in patients with multiple sclerosis 94
Interferone beta1b: bilancio su un gruppo di 30 pazienti 92
Multiple sclerosis in twins from continental Italy and Sardinia: a nationwide study 89
Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis 88
Long-term efficacy and tolerability of natalizumab treatment in multiple sclerosis patients: a multicentre experience in Italy 80
Spinal cord injury in a patient with multiple sclerosis (MS) with secondary hydromyelia 79
Totale 6.519
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.797
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.797
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022208 0 0 6 49 6 2 6 19 12 3 31 74
2022/2023806 58 122 45 83 86 164 40 56 108 6 23 15
2023/2024397 34 18 25 6 29 164 72 3 1 7 2 36
2024/2025893 60 99 111 13 13 31 19 31 62 43 197 214
2025/20262.140 191 80 250 323 225 106 359 93 220 153 94 46
2026/2027144 38 94 12 0 0 0 0 0 0 0 0 0
Totale 6.519